Physiological Effects of High-Flow Tracheal Oxygen Via An Modified Interface
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03244761|
Recruitment Status : Completed
First Posted : August 10, 2017
Last Update Posted : February 12, 2018
|Condition or disease||Intervention/treatment|
|Tracheostomy||Procedure: The modified HFT|
|Study Type :||Observational|
|Actual Enrollment :||20 participants|
|Official Title:||Physiological Effects of High-Flow Tracheal Oxygen Via An Modified Interface in Tracheostomized Patients|
|Actual Study Start Date :||July 1, 2017|
|Actual Primary Completion Date :||September 15, 2017|
|Actual Study Completion Date :||February 5, 2018|
The standard HFT
The high-flow oxygen was delivered via tracheostomy using a standard HFT.
The modified HFT
The high-flow oxygen was delivered via tracheostomy using a modified HFT.
Procedure: The modified HFT
The HFT was modified by increasing the expiratory resistance.
- The mean end expiratory pressure. [ Time Frame: the last 1 minutes of steady breathing during the standard or modified HFT. ]The patients was delivering the high flow oxygen via the standard and modified HFT interface for 20 minutes.
- Changes in global and regional EELV [ Time Frame: the last 1 minutes of steady breathing during the standard or modified HFT. ]The Electrical impedance tomography (EIT) was applied in monitoring the change of EELV at the bedside.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03244761
|Beijing, Beijing, China, 100050|
|Principal Investigator:||Jian-Xin Zhou, MD||Beijing Tiantan Hospital|